Nebulizer (direct Patient Interface)

Device Code: 83

Product Code(s): CAF

Device Classification Information

Device Type ID83
Device NameNebulizer (direct Patient Interface)
Regulation DescriptionNebulizer.
Regulation Medical SpecialtyAnesthesiology
Review PanelAnesthesiology
Premarket Review Office Of Device Evaluation (ODE)
Division Of Anesthesiology, General Hospital, Infection Control, And Dental Devices (DAGRID)
Respiratory Devices Branch (RPDB)
Submission Type510(k)
CFR Regulation Number868.5630 [🔎]
FDA Device ClassificationClass 2 Medical Device
Product CodeCAF
GMP ExemptNo
Summary MREligible
Implanted DeviceNo
Life Support DeviceNo
Third Party Review Eligible For Accredited Persons Program

Recognized Standards

Total Product Life Cycle

Device Type ID83
DeviceNebulizer (direct Patient Interface)
Product CodeCAF
FDA Device ClassificationClass 2 Medical Device
Regulation DescriptionNebulizer.
CFR Regulation Number868.5630 [🔎]
Premarket Reviews
ManufacturerDecision
ADHERIUM (NZ) LTD
 
SUBSTANTIALLY EQUIVALENT
4
AEROGEN LTD.
 
SUBSTANTIALLY EQUIVALENT
1
BESMED HEALTH BUSINESS CORP.
 
SUBSTANTIALLY EQUIVALENT
1
CAREFUSION
 
SUBSTANTIALLY EQUIVALENT
1
DIGIO2 INTERNATIONAL CO., LTD
 
SUBSTANTIALLY EQUIVALENT
1
INSTRUMENTATION INDU
 
SUBSTANTIALLY EQUIVALENT
1
MEDIANATECHNOLOGIES CORP
 
SUBSTANTIALLY EQUIVALENT
1
NEXUS6, LTD.
 
SUBSTANTIALLY EQUIVALENT
1
OMRON HEALTHCARE, INC.
 
SUBSTANTIALLY EQUIVALENT
1
PHILIPS MEDICAL SYSTEMS INTERNATIONAL BV
 
SUBSTANTIALLY EQUIVALENT
1
PRE HOLDING, INC.
 
SUBSTANTIALLY EQUIVALENT
1
RECIPROCAL LABS CORPORATION
 
SUBSTANTIALLY EQUIVALENT
4
SUZHOU WEIKANG MEDICAL APPARATUS CO.,LTD
 
SUBSTANTIALLY EQUIVALENT
1
TELEFLEX MEDICAL
 
SUBSTANTIALLY EQUIVALENT
3
TELEFLEX MEDICAL, INC.
 
SUBSTANTIALLY EQUIVALENT
3
TRUDELL MEDICAL INT'L
 
SUBSTANTIALLY EQUIVALENT
1
VECTURA GMBH
 
SUBSTANTIALLY EQUIVALENT
1
Device Problems
Failure To Deliver
205
Connection Problem
106
Leak / Splash
100
Infusion Or Flow Problem
83
No Flow
55
Disconnection
44
Inaccurate Delivery
37
Fitting Problem
37
Electrical /Electronic Property Problem
25
Device Operates Differently Than Expected
18
Decrease In Pressure
14
Peeled / Delaminated
13
Degraded
13
Improper Flow Or Infusion
10
Detachment Of Device Or Device Component
9
Break
7
Fluid Leak
7
Gas Leak
7
Therapeutic Or Diagnostic Output Failure
6
Restricted Flow Rate
6
Cut In Material
5
Defective Device
5
Detachment Of Device Component
5
Overheating Of Device
4
Noise, Audible
4
Material Rupture
4
Component Missing
4
Fire
4
Improper Or Incorrect Procedure Or Method
4
Device Inoperable
3
Device Operational Issue
3
Use Of Device Problem
3
Loose Or Intermittent Connection
3
Air Leak
3
Failure To Power Up
2
Material Separation
2
Kinked
2
Device Damaged Prior To Use
2
Device Rinsing Issue
2
Temperature Problem
2
Insufficient Information
2
Mechanical Problem
2
Obstruction Of Flow
2
Maintenance Does Not Comply To Manufacturers Recommendations
2
Adverse Event Without Identified Device Or Use Problem
2
Insufficient Heating
2
Defective Component
2
Tear, Rip Or Hole In Device Packaging
1
Material Integrity Problem
1
Device Fell
1
Unstable
1
Human-Device Interface Problem
1
Sparking
1
Burst Container Or Vessel
1
Device Reprocessing Problem
1
Delivered As Unsterile Product
1
Occlusion Within Device
1
Chemical Problem
1
Material Frayed
1
Activation, Positioning Or Separation Problem
1
Crack
1
Delivery System Failure
1
Power Switch
1
Filtration Problem
1
Device Markings / Labelling Problem
1
Manufacturing, Packaging Or Shipping Problem
1
Moisture Or Humidity Problem
1
Complete Loss Of Power
1
Thermal Decomposition Of Device
1
Installation-Related Problem
1
Misassembly By Users
1
Device Handling Problem
1
Patient Device Interaction Problem
1
Hole In Material
1
Incorrect Device Or Component Shipped
1
No Pressure
1
Pressure Problem
1
Total Device Problems 912
Recalls
Manufacturer Recall Class Date Posted
1
Aerogen Ltd.
II Oct-23-2014
2
Compass Health Brands
II Jun-06-2015
3
Medex Cardio-Pulmonary Inc., D.b.a. Smiths Medical Company
I Feb-04-2019
4
Nephron Pharmaceuticals Corp.
II Jun-27-2016
5
Pharmacaribe Llc
II Feb-10-2016
6
SANRAI INTERNATIONAL LLC
II Mar-26-2019
7
Salter Labs
II Feb-10-2016
8
Salter Labs
II Sep-17-2015
9
Teleflex Medical
II Dec-12-2014
10
Thayer Medical Corporation
II Feb-07-2017
11
Valeant Pharmaceuticals North America LLC
II Dec-04-2015
12
Valeant Pharmacueticals International
II Jan-17-2018
13
Valeant Pharmacueticals International
II Jan-21-2016
TPLC Last Update: 2019-04-02 19:28:02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.